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Background: Atherosclerosis and psoriasis (PS) are chronic inflammatory diseases that exhibit epidemiological, immunopathological and clinical 
similarities. Results have suggested that PS may be an independent risk factor for cardiovascular disease. The significance of PS for the risk of 
undergoing percutaneous coronary intervention (PCI) is unknown.
Methods: The study population comprised the entire Danish population aged > 10 years on January 1th 1997 (n = 4,614,840) and subjects were 
followed until December 31th 2006 or death. Patients with PS were identified by individual-level-linkage of nationwide administrative registers of 
hospitalizations and claimed drug prescriptions. Incident PS was identified by the first use of topical vitamin-D prescriptions. Patients undergoing 
continuous hospital-based PS treatment were classified as having moderate/severe PS. Risk of myocardial infarction (MI), PCI or death was analyzed 
by time-dependent Poisson regression models.
Results: A total of 40,262 patients with incident PS were identified and stratified as having mild (n=38,774) or moderate/severe PS (n=2,854). 
The mean age at entry was 46.4 years for mild PS (49.8% men) 44.3 years for moderate/severe PS (51.3% men), and 44.2 years for controls without 
PS (49.1% men). Mild PS did not confer increased risk of all-cause mortality (relative risk [RR] 1.04; 95% confidence interval [CI] 0.97-1.12), but 
moderate/severe PS was associated with an increased risk of death (RR 1.67; CI 1.49-1.87). The risk of MI was not raised in mild PS (RR 1.10; CI 
0.98-1.24) but in moderate/severe PS (RR 1.24; CI 1,14-1.48). PS conferred increased risk of PCI for both mild PS (RR 1.29; CI 1.06-1.57) and 
moderate/severe PS (RR 1.59; CI 1.23-2.05). The increased risks of MI and PCI in patients with moderate/severe PS were age-dependent, e.g., RR 
1.55 (CI 1.05-2.28) and RR 2.0 (CI 1.28-3.12), respectively, in patients aged <50 years at study entry.
Conclusions: This first nationwide study shows that PS is a risk factor for MI and PCI, especially in young patients with moderate/severe disease. 
The results suggest that these patients should be subjected to aggressive cardiovascular risk factor modification.
